Criteria-based probable REM sleep behaviour disorder and risk of Lewy body dementia: analyses of a memory clinic cohort and a community cohort

Abstract Background REM sleep behaviour disorder (RBD) is the strongest prodromal marker of alpha-synucleinopathies, but whether a brief questionnaire carries prognostic information for Lewy body dementia is unclear. We tested whether criteria-based probable RBD (pRBD)—a questionnaire algorithm requiring both core clinical features specified in the International Classification of Sleep Disorders, Third Edition (ICSD-3)—shows a subtype-specific association pattern, defined as an association with incident Lewy body dementia (LBD; dementia with Lewy bodies [DLB] or Parkinson’s disease dementia [PDD]) but not with all-cause dementia. Methods Retrospective analysis of prospectively collected data from two independent cohorts—a memory clinic cohort ( n = 619; median follow-up 3.4 years) and the community-based Korean Longitudinal Study on Cognitive Aging and Dementia (KLOSCAD; n = 5274; 6.4 years). Criteria-based pRBD required dream-enactment behaviour (RBD Screening Questionnaire item 3) plus at least one complex nocturnal motor behaviour (items 6.1–6.3). Cause-specific hazard models estimated associations with incident LBD (clinic) and all-cause dementia (KLOSCAD), with the competing dementia subtype or death as competing events. Sensitivity analyses included inverse probability of censoring weighting, interval-censoring imputation and Firth-penalised estimation. Results In the memory clinic, 34 of 619 patients (5.5%) screened positive, of whom 5 (14.7%) developed LBD compared with 21 of 585 (3.6%) who screened negative (cause-specific hazard ratio [HR] 4.82, 95% CI: 1.54–15.10); there was no association with all-cause dementia (HR 1.00, 95% CI: 0.57–1.76). Of the 26 LBD events, 23 were DLB and 3 were PDD. In KLOSCAD, pRBD was not associated with all-cause dementia (HR 0.92, 95% CI: 0.47–1.81). An exploratory KLOSCAD analysis based on only nine LBD events (6 DLB, 3 PDD) produced a large but very imprecise estimate (HR 8.99, 95% CI: 1.71–47.17) that is hypothesis-generating rather than replication. Conclusions In memory clinic patients, criteria-based pRBD was associated with incident LBD but not with all-cause dementia. The community cohort showed no all-cause association. This subtype-specific profile supports further evaluation of the screen for prioritising alpha-synucleinopathy assessment, pending validation with polysomnography-confirmed RBD. These findings rest on 26 events in a cohort in which only a minority of registered patients returned, and require confirmation.

Authors

Publication Details

Journal
Alzheimer s Research & Therapy
Published
2026-10-02
DOI
https://doi.org/10.1186/s13195-026-02207-0
Primary Topic
Parkinson's Disease Mechanisms and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Criteria-based probable REM sleep behaviour disorder and risk of Lewy body dementia: analyses of a memory clinic cohort and a community cohort

Shin Gyeom Kim, Seok Woo Moon, Seok Bum Lee, Seung‐Ho Ryu et al.
Alzheimer s Research & Therapy
Parkinson's Disease Mechanisms and Treatments
article

Criteria-based probable REM sleep behaviour disorder and risk of Lewy body dementia: analyses of a memory clinic cohort and a community cohort

Shin Gyeom Kim, Seok Woo Moon, Seok Bum Lee, Seung‐Ho Ryu, Kyung Phil Kwak, Ki Woong Kim, Jeong Lan Kim, Ji Won Han, Tae Hui Kim, Joon Hyuk Park, Dae Jong Oh, Dong Woo Lee, Jung Jae Lee, Bong-Jo Kim, Jin Hyeong Jhoo, Yu Jung Choi
article en

Abstract

Abstract Background REM sleep behaviour disorder (RBD) is the strongest prodromal marker of alpha-synucleinopathies, but whether a brief questionnaire carries prognostic information for Lewy body dementia is unclear. We tested whether criteria-based probable RBD (pRBD)—a questionnaire algorithm requiring both core clinical features specified in the International Classification of Sleep Disorders, Third Edition (ICSD-3)—shows a subtype-specific association pattern, defined as an association with incident Lewy body dementia (LBD; dementia with Lewy bodies [DLB] or Parkinson’s disease dementia [PDD]) but not with all-cause dementia. Methods Retrospective analysis of prospectively collected data from two independent cohorts—a memory clinic cohort ( n = 619; median follow-up 3.4 years) and the community-based Korean Longitudinal Study on Cognitive Aging and Dementia (KLOSCAD; n = 5274; 6.4 years). Criteria-based pRBD required dream-enactment behaviour (RBD Screening Questionnaire item 3) plus at least one complex nocturnal motor behaviour (items 6.1–6.3). Cause-specific hazard models estimated associations with incident LBD (clinic) and all-cause dementia (KLOSCAD), with the competing dementia subtype or death as competing events. Sensitivity analyses included inverse probability of censoring weighting, interval-censoring imputation and Firth-penalised estimation. Results In the memory clinic, 34 of 619 patients (5.5%) screened positive, of whom 5 (14.7%) developed LBD compared with 21 of 585 (3.6%) who screened negative (cause-specific hazard ratio [HR] 4.82, 95% CI: 1.54–15.10); there was no association with all-cause dementia (HR 1.00, 95% CI: 0.57–1.76). Of the 26 LBD events, 23 were DLB and 3 were PDD. In KLOSCAD, pRBD was not associated with all-cause dementia (HR 0.92, 95% CI: 0.47–1.81). An exploratory KLOSCAD analysis based on only nine LBD events (6 DLB, 3 PDD) produced a large but very imprecise estimate (HR 8.99, 95% CI: 1.71–47.17) that is hypothesis-generating rather than replication. Conclusions In memory clinic patients, criteria-based pRBD was associated with incident LBD but not with all-cause dementia. The community cohort showed no all-cause association. This subtype-specific profile supports further evaluation of the screen for prioritising alpha-synucleinopathy assessment, pending validation with polysomnography-confirmed RBD. These findings rest on 26 events in a cohort in which only a minority of registered patients returned, and require confirmation.

Alzheimer s Research & Therapy
Openalex Percentile: Top 12%
Parkinson's Disease Mechanisms and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.